IMMUNOSUPPRESSION WITHDRAWAL IN LIVER TRANSPLANT RECIPIENTS ON SIROLIMUS

As conversion from calcineurin inhibitor (CNI) to sirolimus (SRL), an mTOR-inhibitor (mTOR-I), has been shown to enhance immunoregulatory profiles in liver transplant recipients (LTR), mTOR-I therapy might allow for increased success with immunosuppression withdrawal. Our aim was to determine if ope...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Hepatology
मुख्य लेखकों: Levitsky, Josh, Burrell, Bryna E., Kanaparthi, Sai, Turka, Laurence A., Kurian, Sunil, Sanchez-Fueyo, Alberto, Lozano, Juan J., Demetris, Anthony, Lesniak, Andrew, Kirk, Allan D., Stempora, Linda, Yang, Guang-Yu, Mathew, James M.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2020
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7217743/
https://ncbi.nlm.nih.gov/pubmed/31721246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.31036
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन